July 16, 2024
For extra info, contact:
Nicole Fawcett, [email protected]
Many breast most cancers survivors don’t obtain genetic testing, regardless of being eligible
Genetic testing outcomes can inform most cancers remedy, survivorship care and members of the family’ most cancers danger
ANN ARBOR, Michigan — As most cancers remedy and survivorship care depends extra on understanding the genetic make-up of a person’s tumor, a brand new research from the College of Michigan Well being Rogel Most cancers Heart finds that many breast most cancers survivors who meet standards for genetic counseling and testing should not receiving it.
The excellent news: Amongst those that do get testing, practically two-thirds who’ve a genetic variant are reaching out to members of the family to speak about their outcomes.
“Our findings help a quickly rising motion to simplify medical tips to extend entry to genetic testing and medical affect of the outcomes after analysis and into survivorship,” mentioned lead research creator Steven J. Katz, M.D., M.P.H., professor of inner drugs and of well being administration and coverage on the College of Michigan.
Researchers surveyed 1,412 ladies seven months and once more six years after they have been identified with early stage breast most cancers. The sufferers have been recognized via Georgia and Los Angeles County Surveillance Epidemiology and Finish Outcomes, or SEER, registries. Contributors have been requested whether or not they obtained genetic counseling or testing and if that’s the case, whether or not they talked with relations about outcomes.
Medical tips are altering to incorporate extra individuals eligible for genetic testing. The exams themselves are together with extra genes that might assist information not solely remedy however follow-up care and screening. Outcomes may affect members of the family who can also be at elevated danger of most cancers.
The research discovered that practically three-quarters of sufferers who have been eligible for genetic testing at analysis obtained it over the research interval. Simply over half of sufferers who had indications for testing throughout follow-up care obtained it and a couple of third with no indications obtained testing.
Those that obtained testing and located that they had a genetic variant have been almost certainly to speak with their household concerning the outcomes in contrast with those that didn’t.
Researchers additionally discovered that few individuals have been taken with direct-to-consumer genetic exams, which aren’t as subtle as clinical-based genetic testing and counseling. Outcomes are printed within the Journal of Medical Oncology.
“Genetic danger analysis and testing can fall via the cracks throughout survivorship as sufferers’ wants for ongoing remedies, managing the side-effects of remedies, and monitoring for recurrence or development develop,” mentioned senior research creator Lauren Wallner, Ph.D., M.P.H., affiliate professor of inner drugs and epidemiology at U-M. Wallner can be the co-leader of Rogel’s most cancers management and inhabitants sciences program.
“Our findings reinforce the necessity for novel approaches to genetic danger analysis and testing in observe to focus on prevention and early detection methods for his or her sufferers and their households,” mentioned senior research creator Allison Kurian, M.D., M.Sc., professor of drugs and of epidemiology and inhabitants well being at Stanford Drugs.
Researchers have further research deliberate to have a look at how survivorship care is coordinated between oncologists and first care suppliers with a purpose of enhancing survivorship care.
Extra authors: Paul Abrahamse, Allison Furgal, Rachel Hodan, Rachel S. Tocco, Kevin C. Ward, Ann S. Hamilton
Funding for this work is from American Most cancers Society grant RSG-19-015-01, Nationwide Most cancers Institute grants P01 CA163233 and P30 CA046592
Disclosure: None
Paper cited: “Genetic counseling, testing and household communication into survivorship after analysis of breast most cancers,” Journal of Medical Oncology. DOI: 10.1200/JCO.24.00122
Assets:
College of Michigan Rogel Most cancers Heart, www.rogelcancercenter.org
Michigan Drugs Most cancers AnswerLine, 800-865-1125
# # #
